tiprankstipranks
Trending News
More News >
HBM Holdings Ltd. (HK:2142)
:2142
Hong Kong Market
Advertisement

HBM Holdings Ltd. (2142) Similar Stocks

Compare
4 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
HBM Holdings Ltd.
HK$12.39
HK$10.41B
428.97
968.10%
1 Buy
1 Hold
0 Sell
Moderate Buy
Alphamab Oncology
HK$10.98
HK$10.52B
57.57
350.00%
0 Buy
1 Hold
0 Sell
Hold
Lepu Biopharma Co. Ltd. Class H
HK$10.18
HK$18.92B
296.34%
0 Buy
0 Hold
0 Sell
Hold
Abbisko Cayman Limited
HK$16.66
HK$11.44B
60.09
457.19%
1 Buy
1 Hold
0 Sell
Moderate Buy
CStone Pharmaceuticals
HK$10.21
HK$13.90B
645.26%
1 Buy
1 Hold
0 Sell
Moderate Buy
Shandong Boan Biotechnology Company., Limited. Class H
HK$15.60
HK$10.02B
104.21
73.14%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:2142
HBM Holdings Ltd.
12.39
11.22
958.97%
HK:9966
Alphamab Oncology
10.98
8.45
333.99%
HK:2157
Lepu Biopharma Co. Ltd. Class H
9.75
7.34
304.56%
HK:2256
Abbisko Cayman Limited
16.66
13.64
451.66%
HK:2616
CStone Pharmaceuticals
10.21
8.84
645.26%
HK:6955
Shandong Boan Biotechnology Company., Limited. Class H
15.60
6.54
72.19%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis